Novo Nordisk beats earnings expectations as Wegovy, Ozempic demand soars

Novo Nordisk beats earnings expectations as Wegovy, Ozempic demand soars

Liselotte Sabroe | Afp | Getty Images Novo Nordisk, Europe’s largest company by market capitalization, on Wednesday reported better-than-expected 2023 earnings, as sales of its wildly popular anti-obesity and diabetes drugs continued to soar. The maker of weight loss drug Wegovy and diabetes drug Ozempic reported an increase in sales of 31% in Danish kroner … Read more

Vertex non-opioid painkiller shows positive late-stage trial results

Vertex non-opioid painkiller shows positive late-stage trial results

A sign hangs in front of the world headquarters of Vertex Pharmaceuticals in Boston on Oct. 23, 2019. Brian Snyder | Reuters Vertex Pharmaceuticals on Tuesday said its experimental painkiller, which is being tested as an alternative to addictive opioids, significantly decreased post-surgery pain in late-stage trials The drug, known as VX-548, did not work … Read more

J&J, Merck and Bristol Myers Squibb in the hot seat

J&J, Merck and Bristol Myers Squibb in the hot seat

Think a friend or colleague should be getting this newsletter? Share this link with them to sign up. Good afternoon! This is Annika Kim Constantino, and I cover the biotech and pharmaceutical industry for CNBC.com.  Three names in the industry – Johnson & Johnson, Merck and Bristol Myers Squibb – face a pivotal few weeks … Read more

Excessive screen time symptoms cost the U.S. $73 billion a year: Study

Excessive screen time symptoms cost the U.S.  billion a year: Study

American workers are spending too much time looking at screens. More than 104 million people in the U.S., including nearly 70% of people working office jobs, spend upward of seven hours a day looking at screens, according to a Tuesday report from the Deloitte Economics Institute and the American Optometric Association. As a result, symptoms … Read more

Pfizer (PFE) Q4 earnings report 2023

Pfizer (PFE) Q4 earnings report 2023

Pfizer on Tuesday posted a surprise adjusted fourth-quarter profit, as the company’s declining Covid business performed better than expected. The company reversed roughly $3.5 billion in revenue related to the expected return of 6.5 million doses of its Covid drug, Paxlovid, from the U.S. government. That hit is less than the $4.2 billion Pfizer initially expected … Read more

Elon Musk’s Neuralink implants brain tech in human patient for the first time

Elon Musk’s Neuralink implants brain tech in human patient for the first time

Jonathan Raa | Nurphoto | Getty Images Elon Musk’s neurotech startup Neuralink implanted its device in a human for the first time on Sunday, and the patient is “recovering well,” the billionaire said in a post on X, formerly known as Twitter, on Monday. The company is developing a brain implant that aims to help … Read more

Big pharma Merck, Bristol Myers, J&J prepare to lose revenue

Big pharma Merck, Bristol Myers, J&J prepare to lose revenue

The New York Stock Exchange welcomes Johnson & Johnson (NYSE: JNJ) to the podium.  NYSE Big pharmaceutical companies such as Bristol Myers Squibb, Merck and Johnson & Johnson face a looming threat that will put tens of billions of dollars in sales at risk between now and 2030, as blockbuster drugs will tumble off a … Read more

Merck, J&J CEOs agree to testify in Senate hearing on drug prices

Merck, J&J CEOs agree to testify in Senate hearing on drug prices

US Senator Bernie Sanders, Independent of Vermont, speaks during a rally by the People’s Action, protesting pharmaceutical companies’ lobbying against allowing Medicare to negotiate lower prescription drug prices, outside Pharmaceutical Research and Manufacturers of America (PhRMA) headquarters in Washington, DC, September 21, 2021. Saul Loeb | AFP | Getty Images The CEOs of Merck and … Read more

Humana reports grim 2024 forecast due to soaring medical costs

Humana reports grim 2024 forecast due to soaring medical costs

Signage is displayed on a Humana Inc. office building in Louisville, Kentucky, U.S., on Sunday, Feb. 3, 2019. Humana is scheduled to release earnings figures on February 6. Photographer: Luke Sharrett/Bloomberg via Getty Images Bloomberg | Bloomberg | Getty Images Shares of Humana plummeted on Thursday after the health insurer issued dismal full-year earnings guidance, … Read more

Tyson Foods drops CVS, picks Rightway pharmacy benefit manager

Tyson Foods drops CVS, picks Rightway pharmacy benefit manager

Tyson Foods Inc., sign at Tyson headquarters in Springdale, Ark. April L. Brown | AP Tyson Foods will become one of the first Fortune 100 companies to stop using the nation’s traditional large pharmacy benefits managers, as it looks to cut spending on high-cost drugs.    After putting its benefits contract up for bid, Tyson … Read more